Drug Shortage Report for TYPHERIX
| Report ID | 2737 |
| Drug Identification Number | 02242727 |
| Brand name | TYPHERIX |
| Common or Proper name | SALMONELLA TYPHI VI CAPSULAR POLYSACCHARIDE VACCINE |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | SALMONELLA TYPHI VI CAPSULAR POLYSACCHARIDE VACCINE |
| Strength(s) | 25MCG |
| Dosage form(s) | LIQUID |
| Route of administration | INTRAMUSCULAR |
| Packaging size | 1's |
| ATC code | J07AP |
| ATC description | BACTERIAL VACCINES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2016-05-05 |
| Estimated end date | |
| Actual end date | 2017-12-21 |
| Shortage status | Resolved |
| Updated date | 2020-02-27 |
| Company comments | This product has been discontinued. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2020-02-27 | French | Compare |
| v7 | 2020-02-27 | English | Compare |
| v6 | 2017-12-22 | French | Compare |
| v5 | 2017-12-22 | English | Compare |
| v4 | 2017-10-04 | French | Compare |
| v3 | 2017-10-04 | English | Compare |
| v2 | 2017-03-14 | French | Compare |
| v1 | 2017-03-14 | English | Compare |
Showing 1 to 8 of 8